| Symbol | LIANY |
|---|---|
| Name | LIANBIO |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 08540 United States NJ 103 Carnegie Center Drive Suite 309 |
| Telephone | +1 7325131804 |
| Fax | — |
| — | |
| Website | https://www.lianbio.com/ |
| Incorporation | KY |
| Incorporated On | 2019 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | KPMG LLP - New York, New York, (USA); |
| Audit Status | UNAUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0001831283 |
| Description | LianBio ("LianBio" or the "Company") is a clinical stage biopharmaceutical company dedicated to bringing innovative medicines to patients with unmet medical needs in Asia. The Company was incorporated in the Cayman Islands in July 2019 and maintains its Chinese headquarters in Shanghai, China. The Company conducts its corporate activities at its United States headquarters located in Princeton, New Jersey. Additional info from OTC: |